Shaanxi Kanghui Pharmaceutical's subsidiary plans to invest 91 million yuan to establish a joint venture company in Beijing called Huijin.

Shaanxi Kanghui Pharmaceutical (603139.SH) has announced that its wholly-owned subsidiary, Kanghui Zhichuang, will invest 91 million yuan and Beijing Waluer Information Technology will invest 49 million yuan to jointly establish Beijing Huijin Zhichuang Technology Co., Ltd. The target company has a registered capital of 140 million yuan, with Kanghui Zhichuang planning to invest 91 million yuan, accounting for 65% of the registered capital, and Beijing Waluer Information Technology planning to invest 49 million yuan, accounting for 35% of the registered capital. On the same day, Kanghui Zhichuang and Beijing Waluer Information Technology signed a cooperation agreement. Kanghui Zhichuang and Beijing Waluer Information Technology have jointly invested in setting up the joint venture company to expand their business layout and further enhance their market competitiveness. After this external investment is completed, the target company will be included in the company's consolidated financial statements.